Olfr770, a member of the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily, plays a pivotal role in the olfactory system of Mus musculus (house mouse). Similar to other olfactory receptors, Olfr770 is integral to the detection and transduction of odorant molecules, triggering a neuronal response that underlies the perception of smell. This receptor, like its counterparts, possesses a 7-transmembrane domain structure crucial for its functionality in recognizing diverse odorant molecules and activating associated G proteins, thereby initiating intracellular signaling cascades leading to neuronal excitation.
The modulation of Olfr770's function, particularly through inhibition, can be approached via indirect mechanisms due to the intricate nature of GPCR signaling networks and the lack of direct inhibitors. The chemical inhibitors listed, primarily beta-adrenergic receptor antagonists and angiotensin II receptor blockers, serve as potential indirect modulators of Olfr770's activity. These inhibitors operate by altering the signaling dynamics within the GPCR family. For instance, beta-adrenergic receptor antagonists such as bisoprolol and esmolol specifically target beta-1 adrenergic receptors, leading to changes in the adrenergic signaling which could, in turn, affect the signaling pathways related to olfactory receptors. Similarly, angiotensin II receptor antagonists like candesartan and valsartan modulate the angiotensin receptor pathways, which might influence the olfactory receptor functions through altered receptor interactions and systemic signaling modifications. In summary, the inhibition of Olfr770 involves leveraging the broader GPCR signaling networks and understanding the complex interplay between different receptor types. The indirect modulation of Olfr770 through chemical inhibitors underscores the potential for targeted interventions in the realm of sensory perception. This approach highlights the complexity of GPCR signaling and the interconnected nature of cellular signaling mechanisms, providing a window into the modulation of olfactory receptors and the intricacies of olfactory perception.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Bisoprolol | 66722-44-9 | sc-278792 | 25 mg | $204.00 | ||
Bisoprolol is a selective beta-1 adrenergic receptor antagonist. Its specific inhibition of beta-1 receptors can lead to altered GPCR signaling dynamics, potentially impacting olfactory receptor function by modulating G protein-coupled processes. | ||||||
Candesartan | 139481-59-7 | sc-217825 sc-217825B sc-217825A | 10 mg 100 mg 1 g | $46.00 $92.00 $148.00 | 6 | |
Candesartan is an angiotensin II receptor antagonist. By blocking angiotensin receptors, it can indirectly affect GPCR signaling, potentially influencing the activity of olfactory receptors through altered receptor interactions. | ||||||
Irbesartan | 138402-11-6 | sc-218603 sc-218603A | 10 mg 50 mg | $104.00 $297.00 | 3 | |
Irbesartan, an angiotensin II receptor antagonist, modulates cardiovascular function. Its action can indirectly influence GPCR-mediated pathways, including olfactory receptors, by modulating systemic signaling interactions. | ||||||
Esmolol | 81147-92-4 | sc-279019B sc-279019A sc-279019 | 50 mg 100 mg 500 mg | $100.00 $150.00 $650.00 | 1 | |
Esmolol is a selective beta-1 adrenergic receptor blocker. Its action on cardiac receptors can indirectly impact GPCR signaling pathways, including those of olfactory receptors, through systemic modulation of adrenergic signaling. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $71.00 $92.00 | 8 | |
Telmisartan is an angiotensin II receptor blocker with anti-hypertensive properties. Its blockade of angiotensin receptors can indirectly influence GPCR dynamics, potentially affecting olfactory receptor function. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $39.00 $90.00 $120.00 | 4 | |
Valsartan, an angiotensin II receptor antagonist, influences blood pressure control. This action can indirectly modulate GPCR-mediated signaling pathways, potentially impacting olfactory receptor activities. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $67.00 $246.00 | 3 | |
Sotalol is a non-selective beta-adrenergic blocker with antiarrhythmic properties. It can influence GPCR signaling indirectly, potentially affecting olfactory receptor function through altered adrenergic pathway dynamics. | ||||||
Betaxolol | 63659-18-7 | sc-210913 | 10 mg | $212.00 | 1 | |
Betaxolol is a selective beta-1 adrenergic receptor antagonist. Its specific targeting of beta-1 receptors can indirectly affect GPCR signaling, potentially modulating olfactory receptor activities. | ||||||
Olmesartan acid | 144689-24-7 | sc-219481 sc-219481A sc-219481B sc-219481C sc-219481D | 10 mg 500 mg 1 g 2 g 5 g | $153.00 $204.00 $326.00 $523.00 $1051.00 | 7 | |
Olmesartan, an angiotensin II receptor antagonist, is used for managing hypertension. Its action can indirectly influence GPCR signaling, potentially impacting the functionality of olfactory receptors. | ||||||
Nebivolol | 99200-09-6 | sc-279910 | 100 mg | $803.00 | 1 | |
Nebivolol is a selective beta-1 adrenergic receptor antagonist with vasodilatory effects. Its influence on adrenergic pathways can indirectly affect GPCR signaling relevant to olfactory receptors. |